Interactions Between the Hemostatic and Complement Systems

  • Derek Ogston


It would be anticipated that the various systems of the body involved in the defensive responses to injury and the invasion by micro-organisms would function in an integrated manner. These systems include the hemostatic, complement and kinin-forming mechanisms. This chapter reviews the various points of interaction between the hemostatic and complement systems although definitive conclusions on their functional importance is premature.


Platelet Aggregation Complement System Human Platelet Platelet Membrane Tissue Factor Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barbaro, J. F. (1961) ‘The release of histamine from rabbit platelets by means of antigen-antibody precipitations. I. The participation of the immune complex in histamine release’, Journal of Immunology, 86, 369–76Google Scholar
  2. Becker, S., Meuer, S., Hadding, U. and Bitter-Suermann, D. (1978) ‘Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin’, Scandinavian Journal of Immunology, 7, 173–80CrossRefGoogle Scholar
  3. Beller, F.K., Graeff, H. and Gorstein, F. (1969) ‘Disseminated intravascular coagulation during the continuous infusion of endotoxin in rabbit’, American Journal of Obstetrics and Gynecology, 103, 544–54Google Scholar
  4. Benner, K.V., Schumacher, K.-A. and Classen, H.-G. (1975) ‘Platelet aggregation induced by anaphylatoxin and its inhibition’, Arzneimittel-Forschung, 25, 1635–8Google Scholar
  5. Bokisch, V.A., Müller-Eberhard, J. and Cochrane, C.G. (1969) ‘Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum’, Journal of Experimental Medicine, 129, 1109–30CrossRefGoogle Scholar
  6. Bordet, J. (1920) ‘Considerations sur les theories de la coagulation du sang’, Annales de V Institut Pasteur, 34, 561–95Google Scholar
  7. Boulanger, P. and Rice, C.E. (1951) ‘Parallel studies of complement and coagulation: relative effects of dicoumarol’, Canadian Journal of Medical Sciences 29, 5–12Google Scholar
  8. Boyer, J.T., Gall, E.F., Norman, M.E., Nilsson, U.R. and Zimmerman, T.S. (1975) ‘Hereditary deficiency of the seventh component of complement’, Journal of Clinical Investigation, 56, 905–13CrossRefGoogle Scholar
  9. Brade, V., Nicholson, A., Bitter-Suermann, D. and Hadding, U. (1974) ‘Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes’, Journal of Immunology, 113, 1735–43Google Scholar
  10. Breckenridge, R.T., Rosenfeld, S.I., Graff, K.S. and Leddy, J.P. (1977) ‘Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan’, Journal of Immunology, 118, 12–6Google Scholar
  11. Brown, D.L. and Lachmann, P.J. (1973) ‘The behaviour of complement and in lethal endotoxin shock in rabbits’, International Archives of Allergy and Applied Immunology, 45, 193–205CrossRefGoogle Scholar
  12. Brown, D.L. and Lachmann, P.J. (1974) ‘The relationship of complement-mediated platelet damage to intravascular coagulation: comparison between endotoxin and inulin in the rabbit’, Advances in the Biosciences, 12, 300–10Google Scholar
  13. Calcott, M.A. and Müller-Eberhard, H.J. (1972) ‘Clq protein of human complement’, Biochemistry, 11, 3443–50CrossRefGoogle Scholar
  14. Cazenave, J.-P., Assimah, S.N., Painter, R.H., Packham, M.A. and Mustard, J.F. ‘Clq inhibition of the interaction of collagen with human platelets’, Journal of Immunology, 116, 162–3Google Scholar
  15. Chater, B.V. (1976) ‘The role of membrane bound complement in the aggregation of mammalian platelets by collagen’, British Journal of Haematology, 32, 515–24CrossRefGoogle Scholar
  16. Cohen, P. and Gardner, F.H. (1966) ‘Thrombocytopenia as laboratory sign and complication of gram-negative bacteramic infection’, Archives of Internal Medicine, 111, 113–24CrossRefGoogle Scholar
  17. Cooper, N.R. (1979) ‘Interrelationships between the complement system and the coagulation, kinin-forming and fibrinolytic systems’, Thrombosis and Haemostasis, 42, 262Google Scholar
  18. Cooper, N.R., Miles, L.A. and Griffin, J.H. (1979) ‘Activation of purified CI, the first complement component, by purified plasma kallikrein and plasmin’, Thrombosis and Haemostasis, 42, 251Google Scholar
  19. Corrigan, J.J., Ray, W.L. and May, N. (1968) ‘Changes in blood coagulation system associated with septicemia’, New England Journal of Medicine, 279, 851–6CrossRefGoogle Scholar
  20. Davis, A.E. and Kenney, D.M. (1979) ‘Properdin factor D. Effects on thrombin-induced platelet aggregation’, Journal of Clinical Investigation, 64, 721–8CrossRefGoogle Scholar
  21. Davis, A.E., Rosenberg, R.D., Fenton, J.W., Bing, D.H., Rosen, F.S. and Alper, C.A. (1978) ‘Is factor D of the alternative pathway a fragment of thrombin?’ Journal of Immunology, 120, 1771Google Scholar
  22. Delage, J.M., Bergeron, P., Simard, J., Lehner-Netsch, G. and Prochazka, E. ‘Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family’, Journal of Clinical Investigation, 60, 1061–9Google Scholar
  23. Des Prez, R.M. and Bryant, R.E. (1969) ‘Two mechanisms of immunologically-induced injury to rabbit platelets’, Journal of Immunology, 102, 241–52Google Scholar
  24. Des Prez, R.M., Horowitz, H.I. and Hook, E.W. (1961) ‘Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro’, Journal of Experimental Medicine, 114, 857–73CrossRefGoogle Scholar
  25. Dodds, W.J., Raymond, S.L., Moynihan, A.C., Pickering, R.J. and Amiraian, K. (1975) ‘Coagulation studies in C4-deficient guinea pigs’, Thrombosis et Diathesis Haemorrhagica, 34, 602Google Scholar
  26. Donaldson, V.H. (1968) ‘Mechanisms of activation of CI esterase in hereditary angioneurotic edema plasma in vitro. The role of Hageman factor, a clot-promoting agent’, Journal of Experimental Medicine, 127, 411–29CrossRefGoogle Scholar
  27. Eisen, V. and Loveday, C. (1972) ‘Activation of arginine and tyrosine esterase in serum from patients with hereditary angio-oedema’, British Journal of Pharmacology, 46, 157–66Google Scholar
  28. Ekert, H., Friedlander, I. and Hardisty, R.M. (1970) ‘The role of platelets in fibrinolysis. Studies on the plasminogen activator and antiplasmin activity of platelets’, British Journal of Haematology, 18, 575–84CrossRefGoogle Scholar
  29. Fair, D.S., Sundsmo, J.S., Schwartz, B.S., Edgington, T.S. and Müller-Eberhard, H.J. (1981) ‘Prothrombin activation by factor B (Bb) of the alternative pathway of complement’, Thrombosis and Haemostasis, 46, 301Google Scholar
  30. Fong, J.S.C and Good, R.A. (1971) ‘Prevention of the localized and generalized Schwartzman reaction by an anticomplementary agent, cobra venom factor’, Journal of Experimental Medicine, 134, 642–55CrossRefGoogle Scholar
  31. Fong, J.S.C, White, J.G. and Good, R.A. (1974) ‘Inhibition of endotoxic lipopolysaccharide-mediated platelet aggregation by cobra venom anticomplementary factor’, Blood, 44, 399–409Google Scholar
  32. Garner, R., Chater, B.V. and Brown, D.L. (1974) ‘The role of complement in endotoxin shock and disseminated intravascular coagulation: experimental observations in the dog’, British Journal of Haematology, 28, 393–401CrossRefGoogle Scholar
  33. Gewürz, H., Shin, H.S. and Mergenhagen, S.E. (1968) ‘Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components’, Journal of Experimental Medicine, 128, 1049–57CrossRefGoogle Scholar
  34. Ghebrehiwet, B., Silverberg, M. and Kaplan, A.P. (1981) ‘Activation of the classical pathway of complement by Hageman factor fragment’, Journal of Experimental Medicine, 153, 665–76CrossRefGoogle Scholar
  35. Gigli, I. (1978) ‘A single chain precursor of C4 in human serum’, Nature, 272, 836–7CrossRefGoogle Scholar
  36. Gigli, I., Mason, J.W., Colman, R.W. and Austen, K.F. (1968) ‘Interaction of kallikrein with CI esterase inhibitor (ClalNH)’, Journal of Immunology, 101, 814Google Scholar
  37. Gilbert, V.E, and Braude, A.L. (1962) ‘Reduction of serum complement in rabbits after injection of endotoxin’, Journal of Experimental Medicine, 116, 477–90CrossRefGoogle Scholar
  38. Gjonnaess, H. (1972a) ‘Cold-promoted activation of factor VII. III. Relation to the kallikrein system’, Thrombosis et Diathesis Haemorrhagica, 28, 182–93Google Scholar
  39. Gjonnaess, H. (1972b) ‘Cold-promoted activation of factor VII. IV. Relation to the coagulation system’, Thrombosis et Diathesis Haemorrhagica, 28, 194–205Google Scholar
  40. Gocke, D.J. and Osler, A.G. (1965) ‘In vitro damage to rabbit platelets by an unrelated antibody reaction. I. General characteristics of the reaction’, Journal of Immunology, 94, 236–46Google Scholar
  41. Goldberger, G. and Colten, H.R. (1980) ‘Precursor complement protein (pro-C4) is converted in vitro to native C4 by plasmin’, Nature, 286, 514–6CrossRefGoogle Scholar
  42. Gompertjs, E.D. and Rabson, A.R. (1976) ‘Coagulation studies in a patient with homozygous C3 deficiency’, British Journal of Haematology, 35, 165–6CrossRefGoogle Scholar
  43. Henson, P.M. (1970) ‘Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leucocytes and antigen’, Journal of Experimental Medicine, 131, 287–304CrossRefGoogle Scholar
  44. Henson, P.M. and Cochrane, CG. (1969) ‘Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit involving complement’, Journal of Experimental Medicine, 129,161–83Google Scholar
  45. Heusinkveld, R.S., Leddy, IP., Klemperer, M.R. and Breckenridge, R.T. (1974) ‘Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis’, Journal of Clinical Investigation, 53, 554–8CrossRefGoogle Scholar
  46. Horowitz, H.L, Des Prez, R.M. and Hook, E.W. (1962) ‘Effects of bacterial endotoxin on rabbit platelets’, Journal of Experimental Medicine, 115, 619–33CrossRefGoogle Scholar
  47. Humphrey, J.M. and Jaques, R. (1955) ‘The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro)’, Journal of Physiology, 128, 9–27Google Scholar
  48. Jobin, F. and Tremblay, F. (1969) ‘Platelet reactions and immune processes. II. The inhibition of platelet aggregation by complement inhibitors’, Thrombosis et Diathesis Haemorrhagica, 22, 466–81Google Scholar
  49. Kane, M.A., May, J.E. and Frank, M.M. (1973) ‘Interactions of the classical and alternative complement pathways with endotoxin lipopolysaccharide’, Journal of Clinical Investigation, 52, 370–6CrossRefGoogle Scholar
  50. Kondo, M., Hosokawa, K. and Masuda, M. (1976) ‘Cold activation of complement. I. Presence of coagulation-related activator’, Journal of Immunology, 117, 486–90Google Scholar
  51. Laurell, A.-B., Lundh, B. and Malmquist, J. (1965) ‘Inability of a highly purified streptokinase preparation to inactivate complement in serum’, Acta Pathologica et Microbiologica Scandinavia, 64, 318–28Google Scholar
  52. Lepow, I.H., Pillemer, L. and Ratnoff, O.D. (1953) ‘The influence of calcium ions on the inactivation of human complement and its components by plasmin’, Journal of Experimental Medicine, 98, 277–89CrossRefGoogle Scholar
  53. Lepow, LH., Würz, L., Ratnoff, O.D. and Pillemer, L. (1954) ‘Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates’, Journal of Immunology, 73, 146–58Google Scholar
  54. Loos, M. (1977) ‘Generation of EAC42 (C3 convertase) by proteolytic enzymes’, Federation Proceedings, 36, 1209Google Scholar
  55. Marney, S.R. (1971) ‘Rabbit platelet injury by soluble antigen and antibody. II. Aggregation in heparinized plasma and citrated plasma, relationship to ADP and inhibition by cobra factor’, Journal of Immunology, 106, 82–90Google Scholar
  56. McKay, D.G. and Shapiro, S.S. (1958) ‘Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Schwartzman reaction)’, Journal of Experimental Medicine, 107, 353–67CrossRefGoogle Scholar
  57. Moroz, L.A. and Gilmore, N.J. (1976) ‘Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system’, Blood, 48, 531–45Google Scholar
  58. Mueller-Eckhardt, CH. and Lüscher, E.F. (1968) ‘Immune reactions of human blood platelets. A comparative study on the effects of heterologous antiplatelet anti-serum of antigen-antibody complexes of aggregated gamma-globulin and thrombin on platelets’, Thrombosis et Diathesis Haemorrhagica, 20, 155–67Google Scholar
  59. Mulfelder, T.W., Niemetz, J., Kreutzer, D., Beebe, D., Ward, P.A. and Rosenfeld, S.I. (1979) ‘C5 chemotactic fragment induces leukocyte production of tissue factor activity. A link between complement and coagulation’, Journal of Clinical Investigation, 63, 147–50CrossRefGoogle Scholar
  60. Müller-Berghaus, G. and Lohmann, E. (1974) ‘The role of complement in endotoxin-induced disseminated intravascular coagulation: studies in congenitally C6-deficient rabbits’, British Journal of Haematology, 28, 403–18CrossRefGoogle Scholar
  61. Nachman, R.L. (1968) ‘Platelet proteins’, Seminars in Hematology, 5, 18–31Google Scholar
  62. Nagaki, K., Fujikawa, K. and Inal, S. (1965) ‘Studies on the fourth component of complement. II. The fourth component of complement in guinea pig and human platelets’, Biken Journal, 8, 129–41Google Scholar
  63. Nagayama, M., Zucker, M.B. and Beller, F.K. (1971) ‘Effects of a variety of endotoxins on human and rabbit platelet function’, Thrombosis et Diathesis Haemorrhagica, 26, 467–73Google Scholar
  64. Niemetz, J. and Marcus, A.J. (1974) The stimulating effect of platelets and membranes on the procoagulant activity of leucocytes’, Journal of Clinical Investigation, 54, 1437–43CrossRefGoogle Scholar
  65. Niemetz, J., Muhlfelder, T., Chierego, M.E. and Troy, B. (1977) ‘Procoagulant activity of leucocytes’, Annals of the New York Academy of Sciences, 283, 208–17CrossRefGoogle Scholar
  66. Pfueller, S.L. and Lüscher, E.F. (1972) ‘The effect of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities’, Journal of Immunology, 109, 517–25Google Scholar
  67. Pfueller, S.L. and Lüscher, E.F. (1974a) ‘Studies of the mechanisms of the human platelet release reaction induced by immunologic stimuli. I. Complement-dependent and complement-independent reactions’, Journal of Immunology, 112, 1204–10Google Scholar
  68. Pfueller, S.L. and Lüscher, E.F. (1974b) ‘Studies of the mechanisms of the human release reaction induced by immunologic stimuli. II. Effects of zymosan’, Journal of Immunology, 112, 1211–18Google Scholar
  69. Pillemer, L., Ratnoff, O.D. and Lepow, LH. (1953) ‘The inactivation of complement and its components by plasmin’, Journal of Experimental Medicine, 97, 573–89CrossRefGoogle Scholar
  70. Polley, M.J. and Nachman, R. (1978) ‘The human complement system in thrombin-mediated platelet function’, Journal of Experimental Medicine, 147, 1713–26CrossRefGoogle Scholar
  71. Polley, M.J. and Nachman, R.L. (1979) ‘Normal complement in thrombin-mediated platelet function. Uptake of the C5b-9 complex’, Journal of Experimental Medicine, 150, 633–45CrossRefGoogle Scholar
  72. Prydz, H., Allison, A.C. and Schorlemmer, H.U. (1977) ‘Further link between complement activation and blood coagulation’, Nature, 270, 173–4CrossRefGoogle Scholar
  73. Ratnoff, O.D. and Naff, G.B. (1967) ‘The conversion of Cls to CI esterase by plasmin and trypsin’, Journal of Experimental Medicine, 125, 337–58CrossRefGoogle Scholar
  74. Regan, M.G., Lackner, H. and Karpatkin, S. (1974) ‘Platelet function and coagulation profile in lupis erythematosus. Studies in 50 patients’, Annals of Internal Medicine, 81, 462–8Google Scholar
  75. Reid, K.B.M. (1974) ‘A collagen-like amino acid sequence in a polypeptide chain of human Clq (a subcomponent of the first component of complement)’, Biochemical Journal, 141, 189–203Google Scholar
  76. Reid, K.B.M. and Porter, R.R. (1981) ‘The proteolytic activation systems of complement’, Annual Review of Biochemistry, 50, 433–64CrossRefGoogle Scholar
  77. Reid, W.O. and Silver, M.J. (1964) ‘Activation of the blood fibrinolytic enzyme system by platelets’, American Journal of Physiology, 206, 1255–61Google Scholar
  78. Rivers, R.P.A., Hathaway, W.E. and Weston, W.L. (1975) ‘The endotoxininduced coagulant activity of human monocytes’, British Journal of Haematology, 30, 311–6CrossRefGoogle Scholar
  79. Robbins, J. and Stetson, C.A. (1959) ‘An effect of antigen-antibody interaction on blood coagulation’, Journal of Experimental Medicine, 109, 1–8CrossRefGoogle Scholar
  80. Rothberger, H., Zimmerman, T.S., Spiegelberg, H.L. and Vaughan, J.H. (1977) ‘Leucocyte procoagulant activity. Enhancement of production in vitro by IgG and antigen-antibody complexes’, Journal of Clinical Investigation, 59, 549–57CrossRefGoogle Scholar
  81. Saito, H. and Ratnoff, O.D. (1975) ‘Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems’, Journal of Laboratory and Clinical Medicine, 85, 405–15Google Scholar
  82. Saito, H., Ratnoff, O.D., Waldmann, R. and Abraham, J.P. (1975) ‘Fitzgerald trait: deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinin and the property of diluted plasma enhancing vascular permeability (PF/Dil)’, Journal of Clinical Investigation, 55, 1082–9CrossRefGoogle Scholar
  83. Schreiber, A.D. and Austen, K.F. (1974) ‘Hageman factor-independent fibrinolytic pathway’, Clinical and Experimental Immunology, 17, 587–600Google Scholar
  84. Sharp, A.A. (1957) ‘Relationship of complement to blood coagulation’, Nature, 779,632–3CrossRefGoogle Scholar
  85. Siraganian, R.P. (1972) ‘Platelet requirement in the interaction of the complement and clotting systems’, Nature New Biology, 239, 208–10CrossRefGoogle Scholar
  86. Suba, E.A. and Csako, G. (1976) ‘Clq (CI) receptor on human platelets: inhibition of collagen-induced platelet aggregation by Clq (CI) molecules’, Journal of Immunology, 117, 304–9Google Scholar
  87. Sundsmo, J.S. and Wood, L.M. (1981) ‘Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen’, Journal of Immunology, 127, 877–80Google Scholar
  88. Taylor, F.B. and Müller-Eberhard, H.J. (1967) ‘Factors influencing lysis of whole blood clots’, Nature, 216, 1023–5CrossRefGoogle Scholar
  89. Taylor, F.B. and Müller-Eberhard, H.J. (1970) ‘Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets’, Journal of Clinical Investigation, 49, 2068–88CrossRefGoogle Scholar
  90. Taylor, F.B., Nilsson, U.R., Creech, R.H., Carroll, E.T. and Beisswenger, J.G. (1973) ‘Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay in the study of ceratin hypercoagulable states’, Series Haematologica, VI, 4, 529–48Google Scholar
  91. Tiffany, M.L. and Penner, J.A. (1980) ‘Effect of complement on collagen-induced aggregation’, Journal of Laboatory and Clinical Medicine, 96, 796–802Google Scholar
  92. Ward, P.A. (1967) ‘A plasmin-split fragment of C’3 as a new chemotactic factor’, Journal of Experimental Medicine, 126, 189–206CrossRefGoogle Scholar
  93. Wautier, J.L., Tobelem, G.M., Pelter, A.P. and Caen, J.F. (1974) ‘Evidence for CI on human platelets’, Haemostasis, 2, 281–6Google Scholar
  94. Wautier, J.L., Tobelem, G.M., Peltier, A.P. and Caen, J.P. (1976) ‘CI and human. II. Detection by immunological methods and role’, Immunology, 30, 459–65Google Scholar
  95. Wautier, J.L., Souchon, H., Reid, K.B.M., Peltier, A.P. and Caen, J.P. (1977) ‘Studies on the mode of reaction of the first component of complement with platelets; interaction between collagen-like portion of Clq and platelets’, Immunochemistry, 14,763–6CrossRefGoogle Scholar
  96. Wautier, J.L., Peltier, A.P. and Caen, J.P. (1979) ‘Complement (C6) and platelet activation by thrombin in humans’, Thrombosis Research, 15, 589–91CrossRefGoogle Scholar
  97. Wautier, J.L., Legrand, Y.J., Fauvel, F. and Caen, J.P. (1981) ‘Inhibition of collagen interactions by the Cls subcomponent of the first component of complement’, Thrombosis Research, 21, 3–12CrossRefGoogle Scholar
  98. Weksler, B.B. and Coupal, C.E. (1973) ‘Platelet-dependent generation of chemotactic activity in serum’, Journal of Experimental Medicine, 137, 1419–30CrossRefGoogle Scholar
  99. Wooldridge, D., Spragg, J. and Austen, K.F. (1975) ‘Interaction of Hageman factor dependent systems with the complement sequence’, Life Sciences, 16, 802–3CrossRefGoogle Scholar
  100. Zimmerman, T.S. (1974) ‘The platelet in complement-coagulation interaction’, Advances in Biosciences, 12, 291–8Google Scholar
  101. Zimmerman, T.S. and Kolb, W.P. (1976) ‘Human platelet-initiated formation and uptake of the C5–9 complex of human complement’, Journal of Clinical Investigation, 57, 203–11CrossRefGoogle Scholar
  102. Zimmerman, T.S. and Müller-Eberhard, H.J. (1971a) ‘Blood coagulation initiation by a complement-mediated pathway’, Journal of Experimental Medicine, 134, 1601–7CrossRefGoogle Scholar
  103. Zimmerman, T.S. and Müller-Eberhard, H.J. (1971b) ‘Initiation of coagulation by complement activation: generation of platelet associated clot-promoting activity’, Blood, 38, 791Google Scholar
  104. Zimmerman, T.S., Arroyave, CM. and Müller-Eberhard, H.J. (1971) ‘A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6’, Journal of Experimental Medicine, 134, 1591–600CrossRefGoogle Scholar
  105. Zucker, M.B. and Grant, R.A. (1974) ‘Aggregation and release reaction induced in human blood platelets by zymosan’, Journal of Immunology, 112, 1219–30Google Scholar
  106. Zucker, M.B., Grant, R.A., Alper, CA., Goodkofsky, I. and Lepow, I.H. (1974) ‘Requirement for complement components and fibrinogen in the zymosan-induced release reaction of human blood platelets’, Journal of Immunology, 113, 1744–51Google Scholar

Copyright information

© Derek Ogston 1983

Authors and Affiliations

  • Derek Ogston
    • 1
  1. 1.University of AberdeenUK

Personalised recommendations